Tharimmune Statistics

Total Valuation

Tharimmune has a market cap or net worth of $3.08 million. The enterprise value is -$1.70 million.

Market Cap	3.08M
Enterprise Value	-1.70M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Tharimmune has 1.49 million shares outstanding. The number of shares has increased by 2,357.50% in one year.

Current Share Class	1.49M
Shares Outstanding	1.49M
Shares Change (YoY)	+2,357.50%
Shares Change (QoQ)	+60.82%
Owned by Insiders (%)	1.79%
Owned by Institutions (%)	2.11%
Float	1.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.88
P/TBV Ratio	1.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.35

Current Ratio	2.35
Quick Ratio	2.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-837.16

Financial Efficiency

Return on equity (ROE) is -454.53% and return on invested capital (ROIC) is -291.07%.

Return on Equity (ROE)	-454.53%
Return on Assets (ROA)	-165.08%
Return on Capital (ROIC)	-291.07%
Revenue Per Employee	n/a
Profits Per Employee	-$3.62M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.71% in the last 52 weeks. The beta is 1.31, so Tharimmune's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-73.71%
50-Day Moving Average	2.29
200-Day Moving Average	3.71
Relative Strength Index (RSI)	42.66
Average Volume (20 Days)	213,771

Short Selling Information

The latest short interest is 64,984, so 4.37% of the outstanding shares have been sold short.

Short Interest	64,984
Short Previous Month	95,633
Short % of Shares Out	4.37%
Short % of Float	4.45%
Short Ratio (days to cover)	0.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.12M
Pretax Income	-8.88M
Net Income	-10.85M
EBITDA	n/a
EBIT	-11.12M
Earnings Per Share (EPS)	-$11.95

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	4.77M
Total Debt	n/a
Net Cash	4.77M
Net Cash Per Share	$3.21
Equity (Book Value)	3.02M
Book Value Per Share	2.35
Working Capital	3.02M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-9.28M
Capital Expenditures	n/a
Free Cash Flow	-9.28M
FCF Per Share	-$6.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Tharimmune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,357.50%
Shareholder Yield	-2,357.50%
Earnings Yield	-352.75%
FCF Yield	-301.80%

Analyst Forecast

The average price target for Tharimmune is $17.00, which is 721.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.00
Price Target Difference	721.26%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	May 28, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2